These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 38724235)
1. Current treatment options for erectile dysfunction in kidney transplant recipients. Dell'Atti L Sex Med Rev; 2024 Jun; 12(3):442-448. PubMed ID: 38724235 [TBL] [Abstract][Full Text] [Related]
2. The management of erectile dysfunction in men with diabetes mellitus unresponsive to phosphodiesterase type 5 inhibitors. Cayetano-Alcaraz AA; Tharakan T; Chen R; Sofikitis N; Minhas S Andrology; 2023 Feb; 11(2):257-269. PubMed ID: 35929992 [TBL] [Abstract][Full Text] [Related]
4. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Phé V; Rouprêt M Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307 [TBL] [Abstract][Full Text] [Related]
5. The Prevalence and Treatment of Erectile Dysfunction in Male Solid Organ Transplant Recipients. Payne K; Popat S; Lipshultz LI; Thirumavalavan N Sex Med Rev; 2021 Apr; 9(2):331-339. PubMed ID: 31859242 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772 [TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of erectile dysfunction after prostatectomy: An update]. Xu P; Wang YH Zhonghua Nan Ke Xue; 2017 Jul; 23(7):656-662. PubMed ID: 29723462 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis. Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer survivorship: a review of erectile dysfunction and penile rehabilitation after prostate cancer therapy. Chung E; Gillman M Med J Aust; 2014 Jun; 200(10):582-5. PubMed ID: 24882489 [TBL] [Abstract][Full Text] [Related]
10. The medical and surgical treatment of erectile dysfunction: a review and update. Karakus S; Burnett AL Can J Urol; 2020 Aug; 27(S3):28-35. PubMed ID: 32876000 [TBL] [Abstract][Full Text] [Related]
11. Treating erectile dysfunction in renal transplant recipients. Barry JM Drugs; 2007; 67(7):975-83. PubMed ID: 17488143 [TBL] [Abstract][Full Text] [Related]
12. Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: A review of the literature. Afferi L; Pannek J; Louis Burnett A; Razaname C; Tzanoulinou S; Bobela W; da Silva RAF; Sturny M; Stergiopulos N; Cornelius J; Moschini M; Iselin C; Salonia A; Mattei A; Mordasini L Andrology; 2020 Nov; 8(6):1660-1673. PubMed ID: 32741129 [TBL] [Abstract][Full Text] [Related]
13. New treatment options for erectile dysfunction in patients with diabetes mellitus. Basu A; Ryder RE Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369 [TBL] [Abstract][Full Text] [Related]
14. Low intensity extracorporeal shockwave therapy for erectile dysfunction: a study in an Indian population. Srini VS; Reddy RK; Shultz T; Denes B Can J Urol; 2015 Feb; 22(1):7614-22. PubMed ID: 25694008 [TBL] [Abstract][Full Text] [Related]
15. Sexual dysfunction in diabetes. Tamás V; Kempler P Handb Clin Neurol; 2014; 126():223-32. PubMed ID: 25410225 [TBL] [Abstract][Full Text] [Related]
16. Review of the Current Status of Low Intensity Extracorporeal Shockwave Therapy (Li-ESWT) in Erectile Dysfunction (ED), Peyronie's Disease (PD), and Sexual Rehabilitation After Radical Prostatectomy With Special Focus on Technical Aspects of the Different Marketed ESWT Devices Including Personal Experiences in 350 Patients. Porst H Sex Med Rev; 2021 Jan; 9(1):93-122. PubMed ID: 32499189 [TBL] [Abstract][Full Text] [Related]
17. An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction. Jenkins LC; Hall M; Deveci S; Guhring P; Parker M; Nelson CJ; Mulhall JP J Sex Med; 2019 Oct; 16(10):1541-1546. PubMed ID: 31444103 [TBL] [Abstract][Full Text] [Related]
18. The pathogenic role of the immune system in erectile dysfunction and Peyronie's disease: focusing on immunopathophysiology and potential therapeutic strategies. Giagulli VA; Lisco G; De Tullio A; Guastamacchia E; Triggiani V; Jirillo E Sex Med Rev; 2024 Mar; 12(2):210-220. PubMed ID: 38196188 [TBL] [Abstract][Full Text] [Related]